Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 23.9B | 24.4B | 25.0B | 22.2B |
| Cost of revenue | 18.1B | 19.1B | 19.7B | 17.4B |
| Gross profit | 5.8B | 5.3B | 5.3B | 4.8B |
| Operating expense | ||||
| Research & development | 773M | 745M | 780M | 763M |
| Selling general and admin | 2.7B | 2.9B | 3.2B | 3.1B |
| Other operating expenses | — | — | — | — |
| Operating income | 2.3B | 1.7B | 1.3B | 920M |
| Non operating interest income | ||||
| Income | 33M | 35M | 42M | 54M |
| Expense | 344M | 328M | 387M | 359M |
| Other income expense | 124M | 17M | -8M | -68M |
| Pretax income | 2.1B | 1.4B | 989M | 547M |
| Tax provision | 467M | 265M | 148M | -408M |
| Net income | 1.7B | 1.1B | 841M | 955M |
| Basic EPS | 2.2 | 1.6 | 1.2 | 1.4 |
| Diluted EPS | 2.2 | 1.6 | 1.2 | 1.3 |
| Basic average shares | 696.1M | 703M | 708M | 708M |
| Diluted average shares | 713.0M | 717M | 724M | 727M |
| EBITDA | 3.1B | 2.5B | 2.2B | 1.8B |
| Net income from continuing op. | 1.7B | 1.1B | 841M | 955M |
| Minority interests | 1M | 5M | 5M | 5M |
| Preferred stock dividends | — | — | — | — |